logo
Select company
Select metric
-8.03%EBITDA Margin
VS
Market
23
Sector
57
Industry
61
History
78
$ 1.04Close
$ 0.79 - $ 1.9 52-Week Range
Ticker Information

Ticker

IRIX

Company Name

IRIDEX CORP

Sector

Healthcare

Industry

Medical Devices

Exchange

NASDAQ

IRIDEX CORP - EBITDA Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

IRIX - EBITDA % Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA MarginRevenues
6/30/2025$ -3.99M-8.03%$ 49.74M
3/31/2025$ -5.69M-11.65%$ 48.8M
12/31/2024$ -7.42M-15.24%$ 48.67M
9/30/2024$ -9.08M-18.75%$ 48.43M
6/30/2024$ -8.83M-17.76%$ 49.7M
3/31/2024$ -8.78M-17.58%$ 49.92M
12/31/2023$ -7.45M-14.36%$ 51.87M
9/30/2023$ -5.41M-9.91%$ 54.61M
6/30/2023$ -5.66M-10.04%$ 56.39M
3/31/2023$ -5.54M-9.67%$ 57.29M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • IRIDEX CORP's latest trailing twelve months (TTM) EBITDA % stands at -19.82%.
  • Over the past 5 years, IRIDEX CORP's average EBITDA % has been -12.5%.
  • The median EBITDA % for IRIDEX CORP during this period was -13.01%
  • IRIDEX CORP reached its highest EBITDA % over the past 5 years at -4.07%.
  • The lowest EBITDA % recorded by IRIDEX CORP in the same timeframe -19.82%

IRIDEX CORP's EBITDA % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA % Benchmarks
CompanyEBITDA %
ALUR : ALLURION TECHNOLOGIES INC -94.98%COSM : COSMOS HEALTH INC -23.31%RVP : RETRACTABLE TECHNOLOGIES INC -2.17%ADAP : ADAPTIMMUNE THERAPEUTICS PLC -230.09%SSKN : STRATA SKIN SCIENCES INC -13.51%VERO : VENUS CONCEPT INC -53.62%AYTU : AYTU BIOPHARMA INC -6.09%LFWD : LIFEWARD LTD -112.99%ADGM : ADAGIO MEDICAL HOLDINGS INC -23147.96%FLGC : FLORA GROWTH CORP -23.25%

Definition of EBITDA Margin

[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
EBITDA / Revenues
(=) EBITDA %
EBITDA % for IRIDEX CORP is calculated as follows: EBITDA [ $ -7.1M ] / Revenues [ $ 35.8M ]
(=) EBITDA % [ -19.82% ]

IRIX - EBITDA Margin, Last 5 years

-19.82%

Minimum

Sep 30, 2020

-4.07%

Maximum

Jun 30, 2021

-12.5%

Average

-13.01%

Median

EBITDA % Benchmark Analysis

The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.12% with a standard deviation of 26.88%.
The following table provides additional summary stats:
EBITDA % in the Market:
filtered constituents3.29K
min-75.07%
max97.73%
average16.12%
median14.72%
std26.88%